Project Details
Description
Targeting Breast Cancer Tumor Antigens for Immunotherapy - 2020 - 2021 Renewal Targeting Breast Cancer Tumor Antigens for Immunotherapy - 2020 - 2021 Renewal
Status | Finished |
---|---|
Effective start/end date | 10/1/20 → 9/30/21 |
Funding
- Breast Cancer Research Foundation: $141,661.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.